Experimental cell therapy targets dangerous virus in vulnerable transplant patients
Disease control
Recruiting now
This early-stage study is testing whether specially selected immune cells from a donor can safely treat cytomegalovirus (CMV) infections in people who have received a stem cell transplant. The trial is for patients whose CMV infection isn't improving with standard antiviral medic…
Phase: EARLY_PHASE1 • Sponsor: Mari Dallas • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC